Related Experiment Videos
Palmoplantar keratoderma in association with myxedema
Acta Dermato-Venereologica
|January 1, 1986
Summary
Hypothyroidism may cause palmoplantar keratoderma, a skin condition. Thyroid hormone replacement therapy significantly improved the patient's severe hyperkeratosis, suggesting a causal link.
Area of Science:
- Dermatology
- Endocrinology
- Internal Medicine
Background:
- Palmoplantar keratoderma is a skin condition characterized by thickening of the skin on the palms and soles.
- Intractable cases present significant challenges in management.
- The potential link between endocrine disorders and dermatological conditions is an area of ongoing research.
Observation:
- A 63-year-old female presented with a 13-year history of severe, intractable palmoplantar keratoderma.
- The patient was diagnosed with myxedema, a condition associated with hypothyroidism.
- Thyroid hormone substitution therapy was initiated.
Findings:
- Following the initiation of thyroid hormone therapy, the patient experienced a remarkable improvement in her palmoplantar keratoderma.
- This clinical response suggests a direct impact of thyroid hormone levels on skin keratinization.
Implications:
- The findings suggest a potential causal relationship between hypothyroidism and the development of hyperkeratosis, specifically palmoplantar keratoderma.
- This highlights the importance of considering endocrine evaluations in patients with refractory dermatological conditions.
- Further research is warranted to elucidate the underlying mechanisms connecting thyroid function and keratinization disorders.